ACTA DIURNA

Health · Cleveland · Sat Nov 7, 2:23 PM Eastern

Pelacarsen trial lowers Lp(a) but not cardiovascular events

A Cleveland Clinic-led trial found pelacarsen reduced Lp(a) levels by 78.4% but did not lower major cardiovascular events versus placebo over nearly five years.

1 report

• cleveland.com / The Plain DealerMajor heart drug trial falls short of expectations Nov 7, 2:23 PM

In this story: Cleveland Clinic, pelacarsen

Headline and summary written by the Acta Diurna desk using only what the outlets above reported. Read their reporting for the full story. How we stay neutral.

Cleveland news today · More Health · Cleveland prediction markets